| Factor Information | |
|---|---|
| Data ID | 1 |
| Factor | BNP |
| Description | BNP acts as a vasodilator in the fetal-placental vasculature and may participate in cardiac organogenesis of the embryo heart and cardiovascular system. |
| Biomarker | YES |
| Classification | E2 (physiological factor - biochemical index) |
| Association | |
|---|---|
| Application | risk assessment |
| Objective | small-for-gestational-age (SGA) infant |
| p Value | 0.02 |
| OR | 6.7 |
| Conclusion | A maternal BNP over 65.3 pg/mL and maternal SV disease are independent risk factors for delivering an SGA infant. |
| Risk Factor | risk factor (article mentioned) |
| CHD Type | |
|---|---|
| ID | 148 |
| CHD Type | NA |
| CHD Subtype | NA |
| Reference | |
|---|---|
| PMID | 31461203 |
| Year | 2019 |
| Title | BNP Level in Pregnant Women with Congenital Heart Disease Predicts SGA Offspring |
| Sample | ||
|---|---|---|
| Population | pregnant women | |
| Source | blood | |
| Region | Tokyo, Japan | |
| Method | N/A | |
| Race | Asian | |
| Disease History | N/A | |
| Treatment History | N/A | |
| Group | SGA infants(Treatment) | non-SGA infants(Control) |
| Number | 11 | 91 |
| Age | age at pregnancy: 29.3±6.0 years | age at pregnancy: 31.2±4.7 years |
| Gender (Male: Female) | F/M | F/M |
| Marker Level | 160.1±183 pg/ml | 77.1±65.5 pg/ml |
